Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Short-term Investments (2010 - 2026)

Exelixis (EXEL) posted quarterly Short-term Investments of $551.1 million for Q2 2026, down 34.98% year-over-year from $847.6 million in Q2 2025, and down 4.43% quarter-over-quarter from $576.6 million in Q1 2026.

Analysis

Exelixis (EXEL) Short-term Investments (2010 - 2026) Analysis & Trends

Exelixis' Short-term Investments history runs 17 years deep, the most recent figure standing at $551.1 million for Q2 2026.

  • In Q2 2026, Short-term Investments fell 34.98% year-over-year to $551.1 million; the TTM figure through Apr 2026 stood at $551.1 million (down 34.98% YoY), while the FY2026 annual figure was $576.6 million, down 35.5% from the prior year.
  • Short-term Investments for Q2 2026 stood at $551.1 million, down from $576.6 million in the prior quarter.
  • The five-year high for Short-term Investments was $930.8 million in Q3 2024, with the low at $551.1 million in Q2 2026.
  • The 5-year median for Short-term Investments is $802.3 million (2023), against an average of $764.3 million.
  • The sharpest annual moves came in 2024 and 2026: Short-term Investments jumped 31.74% in 2024, then sank 35.5% in 2026.
  • Exelixis' Short-term Investments stood at $807.3 million in 2022, then decreased by 9.29% to $732.3 million in 2023, then grew by 27.11% to $930.8 million in 2024, then plunged by 34.23% to $612.2 million in 2025, then retreated by 9.99% to $551.1 million in 2026.
  • Business Quant data shows EXEL's Short-term Investments at $551.1 million in Q2 2026, $576.6 million in Q1 2026, and $612.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 557.94 Mn
Apr 3, 2026 551.06 Mn
Jan 2, 2026 576.60 Mn
Oct 3, 2025 612.24 Mn
Jul 4, 2025 626.67 Mn
Apr 4, 2025 847.56 Mn
Jan 3, 2025 893.90 Mn
Sep 27, 2024 930.82 Mn
Jun 28, 2024 803.54 Mn
Mar 29, 2024 703.70 Mn
Dec 29, 2023 732.31 Mn
Sep 29, 2023 706.53 Mn
Jun 30, 2023 802.34 Mn
Mar 31, 2023 772.54 Mn
Dec 30, 2022 807.27 Mn
Sep 30, 2022 871.71 Mn
Jul 1, 2022 907.94 Mn
Apr 1, 2022 847.06 Mn
Dec 31, 2021 819.91 Mn
Oct 1, 2021 835.41 Mn